research Functional Evaluation of Novel CYP21A2 Variants: Expanding the Genetic Basis of Non-Classic CAH
Certain genetic variants reduce enzyme activity, contributing to non-classic congenital adrenal hyperplasia.
Search
for
Sort by
Research
990-1000 / 1000+ results 
research Functional Evaluation of Novel CYP21A2 Variants: Expanding the Genetic Basis of Non-Classic Congenital Adrenal Hyperplasia
Certain genetic variants impair enzyme activity, contributing to non-classic congenital adrenal hyperplasia.
research Comparative Study Between Follicular Unit Extraction Technique With or Without Platelet-Rich Plasma in Non-Androgenic Alopecia
PRP did not significantly improve hair restoration results but improved scar tissue quality.
research Trichoscopy as a Diagnostic Method in Non-Scarring Alopecia
Trichoscopy is a quick, accurate, and non-invasive method to diagnose and treat non-scarring hair loss.
research The Safety and Clinical Efficacy of Iron Infusions in Non-Scarring Alopecia Patients
Iron infusions can help improve hair loss in patients who can't take oral iron supplements.
research Non-Scarring Alopecia in Females: A Comprehensive Review
Non-scarring alopecia in females affects emotional well-being and requires accurate diagnosis and personalized treatment.
research A Novel and Safe Modality for Non-Surgical Hair Restoration Using Polydioxanone Monofilament Threads
PDO threads are effective and safe for non-surgical hair restoration.
research Application of Non-Pharmacologic Therapy in Hair Loss Treatment and Hair Regrowth
Non-drug therapies show promise for hair regrowth but need more research.
research Exploring the Relationship Between Immune Cells and Non-Scarring Hair Loss: A Mendelian Randomization Study
Certain immune cells are linked to non-scarring hair loss, suggesting potential for immune-targeted treatments.
research Experience in the Treatment of Non-Scarring Alopecia Areata Using a Biomedical Cell Product Based on Autologous Follicular Stem Cells
Autologous follicular stem cells improved hair loss in 57% of patients.